MAIA Biotechnology increases authorized shares from 70M to 150M after stockholder approval

MAIA Biotechnology, Inc.

Stockholders approved amendment to certificate of incorporation on May 22, 2025.
Certificate of Amendment filed with Delaware Secretary of State on same date.
Authorized common stock raised from 70,000,000 to 150,000,000 shares.
CEO Vlad Vitoc signed the filing on May 23, 2025.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

MAIA Biotechnology, Inc.: Increased authorized common stock from 70,000,000 to 150,000,000 shares (effective 2025-05-22).

Change: charter amendment
Effective: 2025-05-22

Exact text from the filing

On May 22, 2025, stockholders of MAIA Biotechnology, Inc. (the “Company”) approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase its authorized common stock from 70,000,000 shares to 150,000,000 shares.

View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

MAIA Biotechnology, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-012192

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.